DOXTechnology · Software - InfrastructureThe 6 Wall Street analysts covering Amdocs Ltd. hold a median 12-month price target of $75 — +24.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 61 of 100 as at 8 Sept 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores Amdocs Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (99): The share price has been relatively steady.
Momentum (21): The shares have been drifting down relative to others.
Size (20): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on DOX, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +24.6% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 29 June 2026 | Keybanc | Initiates | Sector Weight | — |
| 14 May 2026 | Stifel | Maintains | Buy | — |
| 5 Feb 2026 | Barclays | Maintains | Overweight | — |
| 4 Feb 2026 | Stifel | Maintains | Buy | — |
| 13 Nov 2025 | Wolfe Research | Downgrade | Peer Perform | — |
| 12 Nov 2025 | B of A Securities | Maintains | Buy | — |
| 12 Nov 2025 | Stifel | Maintains | Buy | — |
| 8 July 2025 | Wolfe Research | Initiates | Outperform | — |
| 14 Nov 2024 | Barclays | Maintains | Overweight | — |
| 13 Nov 2024 | Oppenheimer | Maintains | Outperform | — |
| 2 Oct 2024 | Stifel | Initiates | Buy | — |
| 9 May 2024 | Baird | Maintains | Neutral | — |
| 9 May 2024 | Citigroup | Maintains | Buy | — |
| 8 Feb 2024 | Barclays | Maintains | Overweight | — |
| 17 Jan 2024 | Citigroup | Maintains | Buy | — |
| 1 Dec 2023 | Jefferies | Initiates | Buy | — |
| 3 Aug 2023 | Oppenheimer | Maintains | Outperform | — |
| 16 May 2023 | Barclays | Upgrade | Overweight | — |
| 11 May 2023 | Oppenheimer | Reiterates | Outperform | — |
| 2 Feb 2023 | Baird | Maintains | Neutral | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. DOX appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 9 Sept 2026, Amdocs Ltd. returned −28.1% against +18.5% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 48% of US stocks
Cheaper than 63% of US stocks
Cheaper than 48% of US stocks
Cheaper than 48% of US stocks
Higher than 33% of US stocks
Higher than 8% of US stocks
Higher than 49% of US stocks
Higher than 76% of US stocks
Higher than 69% of US stocks
Higher than 71% of US stocks
Higher than 88% of US stocks
Higher than 74% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Amdocs Ltd. has a market value of $6.3B and an enterprise value of $7.4B.
Revenue in the twelve months to 30 June 2026: $4.7B. The latest quarter grew 2.7% year on year.
Net income over the same four quarters: $457.5M, a 9.8% net margin.
Diluted earnings per share, trailing twelve months: $4.20.
Free cash flow in the twelve months to 30 June 2026: $638.8M.
Amdocs Ltd. spent $563.5M on share buybacks and $232.2M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 14.2×; forward P/E: 7.5× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 3.79%, paying out 52% of earnings.
Amdocs Ltd. employs 26,969 people — $173K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Amdocs Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Amdocs Limited presented at Citi's 2026 Global TMT Conference, with a transcript of the presentation published on Seeking Alpha. The company participated in this investor conference, documenting its remarks.
Why it matters — A DOX watcher would care because the presentation offers direct insight into how Amdocs communicates its business to investors at a major industry conference.
Amdocs Limited presented at the Goldman Sachs Communacopia + Technology Conference 2026, with a transcript of the presentation published by Seeking Alpha. The item reports on the company's participation in the conference.
Why it matters — A DOX watcher would care because the conference presentation offers insight into how Amdocs communicates its business narrative to the investment community.
Amdocs (DOX) reported earnings 30 days ago, and its stock has risen 7% since that announcement. The article examines what investors might expect next for the company following the earnings report.
Why it matters — DOX watchers would care because the article assesses the company's recent post-earnings stock performance and outlook following its latest quarterly report.
Amdocs announced that CEO Shimie Hortig and CFO Tal Rozenfeld will speak at the Goldman Sachs Communacopia + Technology Conference on September 8 and at Citi's 2026 Global TMT Conference on September 9. Live webcasts and replays will be available on the company's investor relations website.
Why it matters — A DOX watcher would care because the executive appearances at these major industry conferences offer an opportunity to hear directly from Amdocs leadership about the company's outlook in a high-visibility setting.
Zacks Investment Research highlights Amdocs (DOX) as a strong momentum stock, noting that its Style Scores tool helps investors identify top-rated stocks based on investing style. The piece explains why investors should take advantage of this resource.
Why it matters — The article signals that Amdocs is being recognized favorably by a major research firm for its momentum characteristics, which could be relevant to investors tracking the stock.
The 6 Wall Street analysts covering Amdocs Ltd. have a median 12-month price target of $75, with estimates ranging from $63 to $105. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 6 analysts covering Amdocs Ltd., 3 rate it a Buy, 3 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Amdocs Ltd. 61 out of 100 across roughly 4,600 US stocks as at 8 Sept 2026. None of this is personal advice — it does not consider your circumstances.
As at 8 Sept 2026, Amdocs Ltd. ranks 61 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (99 of 100).
No one can know that. What the data says: the median 12-month target from 6 analysts implies +24.6% from the last close, and Ticker Nerd's factor model ranks Amdocs Ltd. 61 out of 100 as at 8 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Amdocs Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for DOX are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $63 to $105 over the next 12 months.
Amdocs Ltd. returned -28.1% over the 12 months to 9 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
Amdocs Ltd. is a global software and services company focused on the communications, media, and entertainment industries.
The most recent item we track (Seeking Alpha, 9 Sept 2026): "Amdocs Limited (DOX) Presents at Citi's 2026 Global TMT Conference Transcript". Amdocs Limited presented at Citi's 2026 Global TMT Conference, with a transcript of the presentation published on Seeking Alpha. The company participated in this investor conference, documenting its remarks.
Amdocs Ltd. is a global software and services company focused on the communications, media, and entertainment industries. Amdocs provides solutions that help service providers manage customer experience, billing, charging, order management, monetization, and service operations across fixed, mobile, broadband, and digital offerings. Its portfolio includes business support systems, operational support systems, cloud-native platforms, data and AI-enabled tools, and managed services designed to support complex telecom and media environments. The company also works with network automation, digital commerce, subscription management, and content-related workflows, making it a key technology partner for organizations that run large-scale subscriber and service ecosystems. Amdocs Ltd. serves clients in developed and emerging markets and is recognized for helping communications businesses modernize operations, improve efficiency, and deliver integrated digital services.
CEO Mr. Shimie Hortig · 26,969 employees · United States · https://www.amdocs.com
